PSMA therapy is a targeted treatment for metastatic prostate cancer that uses radioligand therapy to slow disease progression ...

Know the questions to ask your doctor about metastatic prostate cancer, such as treatment options, lifestyle changes, and ...

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Oncology Research Program ( ORP) today announced funding awards for quality improvement initiatives in metastatic prostate ...

Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.

Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says one more factor should be considered—chronological age. The study, published ...

Patient reported outcomes (PRO) and tolerability of capivasertib (capi) plus abiraterone (abi) versus placebo (pbo) plus abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate ...

Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...